Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs.
Disease-modifying treatments for multiple sclerosis - a review of approved medications.
Prevalence of Multiple Sclerosis in Tuscany (Central Italy): A Study Based on Validated Administrative Data.
Younger age, female sex, and high number of awakenings and arousals predict fatigue in patients with sleep disorders: a retrospective polysomnographic observational study.
Behçet's syndrome: a critical digest of the 2012-2013 literature.
Yoga effects on physical activity and sexual satisfaction among the Iranian women with multiple sclerosis: a randomized controlled trial.
Alemtuzumab for the treatment of multiple sclerosis.
Patch-Based Segmentation with Spatial Consistency: Application to MS Lesions in Brain MRI.
The clinical features and diagnosis of Metachromatic leukodystrophy: A case series of Iranian Pediatric Patients.
[Animal models for multiple sclerosis].
Tocilizumab and multiple sclerosis: a causal relationship? Clinical Commentary on the case report entitled - MS arising during Tocilizumab therapy for rheumatoid arthritis.
The Toll-like receptor 4-activated neuroprotective microglia subpopulation survives via granulocyte macrophage colony-stimulating factor and JAK2/STAT5 signaling.
MicroRNA Expression Aberration in Chinese Patients with Relapsing Remitting Multiple Sclerosis.
Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis.
Retrospective Cohort Study of Gender Differential in Risk of Multiple Sclerosis in Kuwait.
The effect of balance training on postural control in people with multiple sclerosis using the CAREN virtual reality system: a pilot randomized controlled trial.
[Disease-modifying drugs in pediatric patients with multiple sclerosis].
Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis.
Severe Hypomyelination and Developmental Defects Are Caused in Mice Lacking Protein Arginine Methyltransferase 1 (PRMT1) in the Central Nervous System.
[Emerging new disease--modifying therapies for multiple sclerosis].
Comparison of Compliance And Discontinuation Rates Among Ms Patients Treated With Fingolimod and Other Disease-Modifying Therapies: A Canadian Retrospective Claims Analysis.
Evidence for the Importance of Vitamin D Status in Neurologic Conditions.
Optimizing the initial choice and timing of therapy in relapsing-remitting multiple sclerosis.
Optic neuritis as a possible phenotype of anti-GQ1b/GT1a antibody syndrome.
The role of myelin and oligodendrocytes in axonal energy metabolism.

Pages